Is female sexual dysfunction a medical condition? Drug companies have sure been trying to make you think so, says researcher and journalist Ray Moynihan in his new book, “Sex, Lies and Pharmaceuticals.” Moynihan lambastes drug-industry-financed patient advocacy groups, medical associations and “key opinion leaders” for a global marketing strategy aimed at convincing doctors and regulators that female sexual dysfunction was a medical condition in need of a pharmaceutical treatment.
Female sexual dysfunction – which is claimed to affect up to two thirds of women – is a disorder invented by the pharmaceutical industry to build global markets for drugs to treat it, it is claimed today. Drug companies have invested millions in the search for a female equivalent of Viagra, so far without success. But while doing so they have stoked demand by creating a buzz around the disorder they have created, according to Ray Moynihan, a lecturer at the University of Newcastle in Australia.
Not interested in sex? Perhaps you have a condition called hypoactive sexual desire disorder, caused by a brain chemical imbalance. That’s the message conveyed in a new “educational campaign” launched last week by the Society of Women’s Health Research with actress Lisa Rinna as a celebrity spokesperson talking about “the brain’s potential role in desire.” On the campaign’s new website, you might conclude that if you’re not fantasizing about sex a lot you should definitely talk to your doctor.
A state investigation of Oregon’s Mount Bachelor Academy (MBA) has substantiated allegations made by students and staff that lap dance “therapy” was part of the school’s “emotional growth” curriculum, costing $6,400 in monthly tuition, and forced an emergency shutdown of the campus.